Tag: Drugmaker
Spain’s Antitrust Watchdog Fines Drugmaker For ‘Excessive’ Pricing
Antitrust regulators in Spain have fined a drugmaker $10.6 million for years of “excessive” price hikes on a rare disease medicine, the latest instance...
Spanish Competition Watchdog Fines Drugmaker Leadiant
Spain's competition watchdog has fined Italy-based drugmaker Leadiant Biosciences 10.3 million euros ($10.63 million) for selling an orphan drug at an excessive price, it...
Drugmaker Perrigo To Buy Héra For $2.1B
Perrigo, a pharmaceutical company, has agreed to buy Héra for €1.8 billion (US$2.1 billion), in a merger that would help cement Perrigo’s shift to focus...
Judge OKs Multiple Classes In Ranbaxy Generic Delay Case
A federal judge has approved multiple classes in litigation accusing Indian generic drugmaker Ranbaxy Laboratories of delaying the launch of generic drugs by submitting...
UK Drugmaker Stops Plan To Pull Bipolar Meds After Antitrust Probe
A private equity owned drugmaker is under investigation by the UK’s competition watchdog after its threats to withdraw one of its bipolar medicines triggered...
French Drugmaker Accused of Monopolizing Online Pet Meds Market
A US subsidiary of French veterinary pharmaceutical company Ceva Sante Animale was hit with an antitrust suit in Kansas federal court claiming it monopolized...
US: EpiPen maker may have overcharged taxpayers by $1.27 billion
Mylan Pharmaceuticals, the maker of EpiPens for allergy sufferers, may have overcharged taxpayers as much as $1.27 billion by misclassifying their life-saving devices under...
